• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELG:US

141.5100 USD 0.3500 0.25%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Celgene Corp (CELG)

Open: 141.9800 Day's Range: 140.2900 - 144.0699 Volume: 2,974,766
Previous Close: 141.8600 52wk Range: 110.5301 - 174.6600 1-Yr Rtn: +15.65%

Stock Chart for CELG

No chart data available.
  • CELG:US 141.5100
  • 1D
  • 1M
  • 1Y
141.8600
Interactive CELG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELG

Current P/E Ratio (ttm) 30.2365
Estimated P/E(12/2014) 19.6079
Relative P/E vs. SPX 1.7582
Earnings Per Share (USD) (ttm) 4.6801
Est. EPS (USD) (12/2014) 7.2170
Est. PEG Ratio 0.7671
Market Cap (M USD) 57,455.90
Shares Outstanding (M) 406.02
30 Day Average Volume 4,466,980
Price/Book (mrq) 10.3717
Price/Sale (ttm) 9.0149
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELG

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J HuginChairman/President/CEOJacqualyn A FouseExec VP/CFO
Perry A KarsenExec VP/COOThomas O DanielExec VP/Pres:Research
More Company Profile & Key Executives for CELG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil